BioGaia AB (publ)

kr 122.10As of Sun 8 Nov 2026, 12:00 UTC
STO:BIOG-BHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR 11.41%
Div yield 3.28%
ROE 32.10%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.23
PE TTM 31.56
TSR TTM 25.33%
Mkt cap kr 12.35B
ROIC 54.56%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 130
6.81%
(85.99%)
Hold 3|0|9|8|8
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
1.53
1.59
1.62
1.66
12.53%
18.69%
14.68%
7.96%
Revenuekr M
538.6
549.5
566.0
571.2
(6.12%)
(6.49%)
(1.04%)
2.88%
Peers (US$1.249B)
Cap (US$)
PE
17.53B
26.50x
191.8M
12.31x
77.47M
731.9x
Capital
TTM
5Y
10Y
Leveragex
1.475
0.463
0.381
EBIT/Intx
1.491
0.116
0.130
Own earn%
(94.42)
(191.71)
(146.20)
Sh yield%
33.41
19.36
18.09
Owners
Insiders/Inst%
1.17
33.50
Short interest%
3.39
SBC / revenue%
1.54
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
14–25
$1 testx
—
Incr. ROIC%
2